Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-22T15:27:16.474Z Has data issue: false hasContentIssue false
  • English
  • Français

Iron, magnesium and ischaemic heart disease

Published online by Cambridge University Press:  28 February 2007

Peter C. Elwood
Peter C. Elwood
Affiliation:
MRC Epidemiology Unit, Llandough Hospital, Penarth, South Glamorgan CF64 2XW
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
‘Newer aspects of micronutrients’
Information
Proceedings of the Nutrition Society , Volume 53 , Issue 3 , November 1994 , pp. 599 - 603
Copyright
Copyright © The Nutrition Society 1994

References

Adams, J. H. & Mitchell, J. R. A. (1979). The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Thrombosis and Haemostasis 42, 603–610.Google ScholarPubMed
Anderson, T. W., Neri, L. C., Schreiber, G. B., Talbot, F. D. F. & Zdrojewski, A. (1975). Ischaemic heart disease, water hardness and myocardial magnesium. Canadian Medical Association Journal 113, 199–203.Google ScholarPubMed
Ascherio, A., Willett, W. C., Rimm, E. B., Giovannucci, E. L. & Stampfer, M. J. (1994). Dietary iron intake and risk of coronary disease among men. Circulation 89, 969–974.CrossRefGoogle ScholarPubMed
Biemond, P., Swaak, A. J., Beindorff, C. M. & Koster, J. F. (1986). Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase: implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation. Biochemistry Journal 239, 169–173.CrossRefGoogle ScholarPubMed
Carter, C., McGee, D., Reed, D., Yano, K. & Ftemmermann, G. (1983). Haematocrit and the risk of coronary heart disease: the Honolulu Heart Program. American Heart Journal 105, 674–679.CrossRefGoogle ScholarPubMed
Chipperfield, B. & Chipperfield, J. R. (1973). Heart muscle magnesium, potassium and zinc concentrations after sudden death from heart disease. Lancet ii, 293–296.CrossRefGoogle Scholar
Cross, C. E., Halliwell, B., Borish, E. T., Pryor, W. A., Saul, R. L., McCord, J. M. & Harman, D. (1987). Oxygen radicals and human disease. Annals of Internal Medicine 107, 526–545.CrossRefGoogle ScholarPubMed
Elwood, P. C., Sweetnam, P. M., Beasley, W. H., Jones, D. & France, R. (1980). Magnesium and calcium in the myocardium: cause of death and area differences. Lancet ii, 720–722.CrossRefGoogle Scholar
Gold, M. E., Buga, G. M., Wood, K. S., Byrns, R. E., Chaudhuri, G. & Ignarro, L. J. (1990). Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone. Circulation Research 66, 355–366.CrossRefGoogle ScholarPubMed
Iseri, L. T., Alexander, L. C., McCaughey, R. S., Boyle, A. J. & Myers, G. B. (1952). Water and electrolyte content of cardiac and skeletal muscle in heart failure and myocardial infarction. American Heart Journal 43, 215–227.CrossRefGoogle ScholarPubMed
ISIS Collaborative Group (1993). ISIS-4: randomised study of intravenous magnesium in over 50.000 patients with suspected acute myocardial infarction. Circulation 88, Suppl. I, 292.Google Scholar
Magnusson, M. K., Sigfusson, N., Sigvaldason, H., Johannesson, G. M., Magnusson, S. & Thorgeirsson, G. (1994). Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89, 102–108.CrossRefGoogle ScholarPubMed
Morrison, H. I., Semenciw, R. M., Mao, Y. & Wigle, D. T. (1994). Serum iron and risk of fatal acute myocardial infarction. Epidemiology 5, 243–246.CrossRefGoogle ScholarPubMed
Rude, R. (1989). Physiology of magnesium metabolism and the important role of magnesium in potassium deficiency. American Journal of Cardiology 63, 31G–34G.CrossRefGoogle ScholarPubMed
Salonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R. & Salonen, R. (1992). High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86, 803–811.CrossRefGoogle ScholarPubMed
Sempos, C. T., Looker, A. C., Gillum, R. F. & Makuc, D. M. (1994). Body iron stores and the risk of coronary heart disease. New England Journal of Medicine 330, 1119–1124.CrossRefGoogle ScholarPubMed
The Caerphilly and Speedwell Collaborative Group (1984). Caerphilly and Speedwell collaborative heart disease studies. Journal of Epidemiology and Community Health 38, 259–262.CrossRefGoogle Scholar
Woods, K. L. (1991). Possible pharmacological actions of magnesium in acute myocardial infarction. British Journal of Clinical Pharmacology 32, 3–10.CrossRefGoogle ScholarPubMed
Woods, K. L., Fletcher, S., Roffe, C. & Haider, Y. (1992). Intravenous magnesium sulphate in suspected acutc myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339, 1553–1558.CrossRefGoogle ScholarPubMed
Yarnell, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., Whitehead, P. J. & Elwood, P. C. (1991). Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 83, 836–844.CrossRefGoogle ScholarPubMed
Zoll, P. M., Wessler, S. & Schlesinger, J. (1951). Inter-arterial coronary anastamoses in the human heart with particular reference to anaemia and relative cardiac anoxia. Circulation 4, 797–815.CrossRefGoogle Scholar